Metformin Modulates Systemic Lipid Remodeling after Traumatic Brain Injury.

Area of Science:

• Neuroscience
• Metabolomics
• Pharmacology

Background:

• Traumatic brain injury (TBI) causes systemic metabolic disturbances, especially in lipid metabolism, potentially worsening secondary injury.
• Metformin's effects on mitochondrial function and lipid homeostasis are known, but its impact on the lipidome post-TBI is unclear.

Purpose of the Study:

• To investigate the impact of metformin pretreatment on plasma lipidome alterations following TBI in a porcine model.
• To characterize TBI-induced changes in lipid metabolism and assess metformin's modulatory effects.

Main Methods:

• Plasma lipidomic profiling was conducted in a porcine model with metformin or control pretreatment.
• Univariate and multivariate statistical analyses, including PCA and sPLS-DA, were used for data analysis.
• Within-subject comparisons were performed using paired pre- and post-TBI samples.

Main Results:

• TBI induced significant lipidomic remodeling, with increased triglycerides and decreased phosphatidylinositols.
• Metformin had minimal baseline effects but showed distinct post-TBI alterations in lipid profiles.
• Specific changes included altered patterns of triglycerides, phospholipids, lysophospholipids, and cholesteryl esters post-TBI with metformin.

Conclusions:

• Metformin modulates the systemic lipidomic response following TBI, suggesting a context-dependent therapeutic role.
• Findings highlight the potential of targeting lipid pathways for intervention after TBI.
• Metformin's influence on post-injury metabolic remodeling warrants further investigation.